NewEdge Advisors’s Monogram Orthopaedics MGRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$8.2K Hold
1,396
– – ﹤0.01% 3388
2025
Q2
$4.03K Hold
1,396
– – ﹤0.01% 3466
2025
Q1
$4.1K Sell
1,396
-706
-34% -$1.87K ﹤0.01% 3350
2024
Q4
$4.98K Hold
2,102
– – ﹤0.01% 3236
2024
Q3
$5.57K Hold
2,102
– – ﹤0.01% 3138
2024
Q2
$4.52K Hold
2,102
– – ﹤0.01% 3126
2024
Q1
$5.13K Buy
2,102
+706
+51% +$2.08K ﹤0.01% 3130
2023
Q4
$4.8K Hold
1,396
– – ﹤0.01% 3129
2023
Q3
$3.63K Hold
1,396
– – ﹤0.01% 2895
2023
Q2
$5.56K Buy
+1,396
New +$7.22K ﹤0.01% 2778

Other funds holding MGRM

NewEdge Advisors's MGRM Position: Q3 2025 in Review

NewEdge Advisors held its Monogram Orthopaedics (MGRM) position steady in Q3 2025 at 1,396 shares worth $8.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3388.

NewEdge Advisors first reported a position in MGRM in Q2 2023 and has held it in 10 quarters since. 64 funds tracked by Wall St. Rank hold MGRM as of Q3 2025.

  • NewEdge Advisors held 1,396 shares of Monogram Orthopaedics worth $8.2K as of Q3 2025.
  • NewEdge Advisors left its Monogram Orthopaedics share count unchanged in Q3 2025.
  • Monogram Orthopaedics made up ﹤0.01% of NewEdge Advisors's portfolio in Q3 2025, its #3388 holding.
  • NewEdge Advisors first reported a position in Monogram Orthopaedics in Q2 2023 and has held it in 10 quarters since.
  • 64 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q3 2025.

Based on NewEdge Advisors's 13F filing for Q3 2025, filed 17 Nov 2025.